Skip to main content
Erschienen in: Journal of Thrombosis and Thrombolysis 2/2018

10.05.2018

Congenital hypodysfibrinogenemia associated with a novel deletion of three residues (γAla289_Asp291del) in fibrinogen

verfasst von: Liqing Zhu, Misheng Zhao, Mingshan Wang, Zhefeng Lou, Xiaoli Chen, Liangliang Pan, Dandan Yu, Wenli Xia, Han Wang, Bin Zhou, Shenmeng Gao

Erschienen in: Journal of Thrombosis and Thrombolysis | Ausgabe 2/2018

Einloggen, um Zugang zu erhalten

Abstract

Hypodysfibrinogenemia is the least frequently reported congenital fibrinogen disorder, characterized by both quantity and quality defects of fibrinogen. In this study, we investigated the molecular basis of hypodysfibrinogenemia in a Chinese family. Functional fibrinogen was measured by Clauss method, and the antigenic fibrinogen was measured by immunoturbidimetry assay. All the exons and exon–intron boundaries of fibrinogen genes (FGA, FGB and FGG) were analysed by direct DNA sequencing. To further evaluate its molecular and functional characterizations, fibrinogen was purified from the plasma of propositus, then SDS-PAGE, fibrin polymerization, clot lysis, and electron microscopy scanning were all performed. The propositus showed a slight decrease of immunologic fibrinogen (1.52 g/L) but dramatically reduced functional fibrinogen (0.3 g/L). DNA sequencing revealed a novel heterozygous CCTTTGATG deletion in the exon 8 of FGG, leading to the deletion of Ala289, Phe290, and Asp291 in fibrinogen γ-chain. The polymerization of the fibrinogen from the propositus was markedly impaired, with prolonged lag period and decreased final turbidity. The fibrinogen clottability showed a reduced fraction of participating clot formation. While the clot lysis showed normal. Scanning electron microscopy revealed that the fibers of the propositus were thicker than normal, with larger pores and curlier meshworks. We conclude that γAla289_Asp291del is responsible for the hypodysfibrinogenemia in this case.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
2.
Zurück zum Zitat Mosesson MW, Siebenlist KR, Meh DA (2001) The structure and biological features of fibrinogen and fibrin. Ann N Y Acad Sci 936:11–30CrossRefPubMed Mosesson MW, Siebenlist KR, Meh DA (2001) The structure and biological features of fibrinogen and fibrin. Ann N Y Acad Sci 936:11–30CrossRefPubMed
3.
Zurück zum Zitat Kant JA, Fornace AJ Jr, Saxe D, Simon MI, McBride OW, Crabtree GR (1985) Evolution and organization of the fibrinogen locus on chromosome 4: gene duplication accompanied by transposition and inversion. Proc Natl Acad Sci USA 82:2344–2348CrossRefPubMed Kant JA, Fornace AJ Jr, Saxe D, Simon MI, McBride OW, Crabtree GR (1985) Evolution and organization of the fibrinogen locus on chromosome 4: gene duplication accompanied by transposition and inversion. Proc Natl Acad Sci USA 82:2344–2348CrossRefPubMed
4.
Zurück zum Zitat Mosesson MW (2005) Fibrinogen and fibrin structure and functions. J Thromb Haemost 3:1894–1904CrossRefPubMed Mosesson MW (2005) Fibrinogen and fibrin structure and functions. J Thromb Haemost 3:1894–1904CrossRefPubMed
6.
Zurück zum Zitat Podolnikova NP, Yakovlev S, Yakubenko VP, Wang X, Gorkun OV, Ugarova TP (2014) The interaction of integrin alphaIIbβ3 with fibrin occurs through multiple binding sites in the alphaIIbβ-propeller domain. J Biol Chem 289:2371–2383CrossRefPubMed Podolnikova NP, Yakovlev S, Yakubenko VP, Wang X, Gorkun OV, Ugarova TP (2014) The interaction of integrin alphaIIbβ3 with fibrin occurs through multiple binding sites in the alphaIIbβ-propeller domain. J Biol Chem 289:2371–2383CrossRefPubMed
7.
Zurück zum Zitat de Moerloose P, Casini A, Neerman-Arbez M (2013) Congenital fibrinogen disorders: an update. Semin Thromb Hemost 39:585–595CrossRefPubMed de Moerloose P, Casini A, Neerman-Arbez M (2013) Congenital fibrinogen disorders: an update. Semin Thromb Hemost 39:585–595CrossRefPubMed
8.
Zurück zum Zitat Brennan SO, Davis RL, Lowen R, Ruskova A (2009) Deletion of five residues from the coiled coil of fibrinogen (BβAsn167_Glu171del) associated with bleeding and hypodysfibrinogenemia. Haematologica 94:585–588CrossRefPubMedPubMedCentral Brennan SO, Davis RL, Lowen R, Ruskova A (2009) Deletion of five residues from the coiled coil of fibrinogen (BβAsn167_Glu171del) associated with bleeding and hypodysfibrinogenemia. Haematologica 94:585–588CrossRefPubMedPubMedCentral
9.
Zurück zum Zitat Brennan SO, Davis RL, Mosesson MW, Hernandez I, Lowen R, Alexander SJ (2007) Congenital hypodysfibrinogenaemia (Fibrinogen Des Moines) due to a gamma320Asp deletion at the Ca2+ binding site. Thromb Haemost 98:467–469CrossRefPubMed Brennan SO, Davis RL, Mosesson MW, Hernandez I, Lowen R, Alexander SJ (2007) Congenital hypodysfibrinogenaemia (Fibrinogen Des Moines) due to a gamma320Asp deletion at the Ca2+ binding site. Thromb Haemost 98:467–469CrossRefPubMed
10.
Zurück zum Zitat Casini A, Brungs T, Lavenu-Bombled C, Vilar R, Neerman-Arbez M, de Moerloose P et al (2017) Genetics, diagnosis and clinical features of congenital hypodysfibrinogenemia: a systematic literature review and report of a novel mutation. J Thromb Haemost 15:876–888CrossRefPubMed Casini A, Brungs T, Lavenu-Bombled C, Vilar R, Neerman-Arbez M, de Moerloose P et al (2017) Genetics, diagnosis and clinical features of congenital hypodysfibrinogenemia: a systematic literature review and report of a novel mutation. J Thromb Haemost 15:876–888CrossRefPubMed
11.
Zurück zum Zitat Misheng Zhao M, Wang Z, Lou X, Chen D, Yu X, Li et al (2018) Congenital hypofibrinogenemia associated with γK232T: in vitro expression demonstrates defective secretion of the variant fibrinogen. Hämostaseologie 38:43–48 Misheng Zhao M, Wang Z, Lou X, Chen D, Yu X, Li et al (2018) Congenital hypofibrinogenemia associated with γK232T: in vitro expression demonstrates defective secretion of the variant fibrinogen. Hämostaseologie 38:43–48
12.
Zurück zum Zitat Amri Y, Jouini H, Becheur M, Dabboubi R, Mahjoub B, Messaoud T, Sfar MT et al (2017) Fibrinogen Mahdia: a congenitally abnormal fibrinogen characterized by defective fibrin polymerization. Haemophilia 23:e340–e347CrossRefPubMed Amri Y, Jouini H, Becheur M, Dabboubi R, Mahjoub B, Messaoud T, Sfar MT et al (2017) Fibrinogen Mahdia: a congenitally abnormal fibrinogen characterized by defective fibrin polymerization. Haemophilia 23:e340–e347CrossRefPubMed
13.
Zurück zum Zitat Kamijyo Y, Hirota-Kawadobora M, Yamauchi K, Terasawa F, Honda T, Ikeya M et al (2009) Analysis of plasmin generation and clot lysis of plasma fibrinogen purified from a heterozygous dysfibrinogenemia, BbetaGly15Cys (Hamamatsu II). Blood Coagul Fibrinolysis 20:726–732CrossRefPubMed Kamijyo Y, Hirota-Kawadobora M, Yamauchi K, Terasawa F, Honda T, Ikeya M et al (2009) Analysis of plasmin generation and clot lysis of plasma fibrinogen purified from a heterozygous dysfibrinogenemia, BbetaGly15Cys (Hamamatsu II). Blood Coagul Fibrinolysis 20:726–732CrossRefPubMed
14.
Zurück zum Zitat Spraggon G, Everse SJ, Doolittle RF, Doolittle (1997) Crystal structures of fragment D from human fibrinogen and its crosslinked counterpart from fibrin. Nature 389:455–462CrossRefPubMed Spraggon G, Everse SJ, Doolittle RF, Doolittle (1997) Crystal structures of fragment D from human fibrinogen and its crosslinked counterpart from fibrin. Nature 389:455–462CrossRefPubMed
15.
Zurück zum Zitat Dear A, Brennan SO, Dempfle CE, Kirschstein W, George PM (2004) Hypofibrinogenaemia associated with a novel heterozygous gamma289 Ala→Val substitution (fibrinogen Dorfen). Thromb Haemost 92:1291–1295PubMed Dear A, Brennan SO, Dempfle CE, Kirschstein W, George PM (2004) Hypofibrinogenaemia associated with a novel heterozygous gamma289 Ala→Val substitution (fibrinogen Dorfen). Thromb Haemost 92:1291–1295PubMed
16.
Zurück zum Zitat Brennan SO, Wyatt JM, Fellowes AP, Dlott JS, Triplett DA, George PM (2001) Gamma371 Thr→Ile substitution in the fibrinogen γD domain causes hypofibrinogenaemia. Biochim Biophys Acta 1550:183–188CrossRefPubMed Brennan SO, Wyatt JM, Fellowes AP, Dlott JS, Triplett DA, George PM (2001) Gamma371 Thr→Ile substitution in the fibrinogen γD domain causes hypofibrinogenaemia. Biochim Biophys Acta 1550:183–188CrossRefPubMed
17.
Zurück zum Zitat Bantia S, Mane SM, Bell WR, Dang CV (1990) Fibrinogen Baltimore I: polymerization defect associated with a gamma 292Gly→Val (GGC→GTC) mutation. Blood 76:2279–2283PubMed Bantia S, Mane SM, Bell WR, Dang CV (1990) Fibrinogen Baltimore I: polymerization defect associated with a gamma 292Gly→Val (GGC→GTC) mutation. Blood 76:2279–2283PubMed
18.
Zurück zum Zitat Mosesson MW, Siebenlist KR, Meh DA (2001) The structure and biological features of fibrinogen and fibrin. Ann N Y Acad Sci 936:11–30CrossRefPubMed Mosesson MW, Siebenlist KR, Meh DA (2001) The structure and biological features of fibrinogen and fibrin. Ann N Y Acad Sci 936:11–30CrossRefPubMed
19.
Zurück zum Zitat Blomback B, Hessel B, Hogg D (1978) A two-step fibrinogen–fibrin transition in blood coagulation. Nature 275:501–505CrossRefPubMed Blomback B, Hessel B, Hogg D (1978) A two-step fibrinogen–fibrin transition in blood coagulation. Nature 275:501–505CrossRefPubMed
20.
Zurück zum Zitat Vorjohann S, Fish RJ, Biron-Andréani C, Nagaswami C, Weisel JW, Boulot P et al (2010) Hypodysfibrinogenaemia due to production of mutant fibrinogen alpha-chains lacking fibrinopeptide A and polymerisation knob ‘A’. Thromb Haemost 104:990–997CrossRefPubMedPubMedCentral Vorjohann S, Fish RJ, Biron-Andréani C, Nagaswami C, Weisel JW, Boulot P et al (2010) Hypodysfibrinogenaemia due to production of mutant fibrinogen alpha-chains lacking fibrinopeptide A and polymerisation knob ‘A’. Thromb Haemost 104:990–997CrossRefPubMedPubMedCentral
21.
Zurück zum Zitat Dear A, Dempfle CE, Brennan SO (2004) Fibrinogen Mannheim II: a novel c307 His→Tyr substitution in the cD domain causes hypofibrinogenemia. J Thromb Haemost 2:2194–2199CrossRefPubMed Dear A, Dempfle CE, Brennan SO (2004) Fibrinogen Mannheim II: a novel c307 His→Tyr substitution in the cD domain causes hypofibrinogenemia. J Thromb Haemost 2:2194–2199CrossRefPubMed
Metadaten
Titel
Congenital hypodysfibrinogenemia associated with a novel deletion of three residues (γAla289_Asp291del) in fibrinogen
verfasst von
Liqing Zhu
Misheng Zhao
Mingshan Wang
Zhefeng Lou
Xiaoli Chen
Liangliang Pan
Dandan Yu
Wenli Xia
Han Wang
Bin Zhou
Shenmeng Gao
Publikationsdatum
10.05.2018
Verlag
Springer US
Erschienen in
Journal of Thrombosis and Thrombolysis / Ausgabe 2/2018
Print ISSN: 0929-5305
Elektronische ISSN: 1573-742X
DOI
https://doi.org/10.1007/s11239-018-1678-2

Weitere Artikel der Ausgabe 2/2018

Journal of Thrombosis and Thrombolysis 2/2018 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.